Zimmer Biomet Holdings (ZBH) Change in Receivables (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Change in Receivables of -$14.5 million for Q1 2026, down 177.13% year-over-year from $18.8 million in Q1 2025, and down 112.98% quarter-over-quarter from $111.7 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Change in Receivables (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Change in Receivables history runs 18 years deep, the most recent figure standing at -$14.5 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 177.13% year-over-year to -$14.5 million; the TTM figure through Mar 2026 stood at $94.0 million (up 9.56% YoY), while the FY2025 annual figure was $127.3 million, up 41.92% from the prior year.
- Change in Receivables for Q1 2026 stood at -$14.5 million, down from $111.7 million in the prior quarter.
- The five-year high for Change in Receivables was $111.7 million in Q4 2025, with the low at -$14.5 million in Q1 2026.
- The 5-year median for Change in Receivables is $18.8 million (2025), against an average of $25.8 million.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables jumped 1157.69% in 2022, then sank 2183.33% in 2024.
- Zimmer Biomet Holdings' Change in Receivables stood at $70.2 million in 2022, then declined by 3.99% to $67.4 million in 2023, then decreased by 26.41% to $49.6 million in 2024, then soared by 125.2% to $111.7 million in 2025, then plunged by 112.98% to -$14.5 million in 2026.
- Business Quant data shows ZBH's Change in Receivables at -$14.5 million in Q1 2026, $111.7 million in Q4 2025, and -$3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.50 Mn |
| Jun 30, 2026 | 38.50 Mn |
| Mar 31, 2026 | -14.50 Mn |
| Mar 31, 2026 | -14.50 Mn |
| Dec 31, 2025 | 111.70 Mn |
| Dec 31, 2025 | 111.70 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -200,000.00 |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | 18.80 Mn |
| Mar 31, 2025 | 18.80 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Sep 30, 2024 | 29.90 Mn |
| Sep 30, 2024 | 29.90 Mn |
| Jun 30, 2024 | -12.50 Mn |
| Jun 30, 2024 | -12.50 Mn |
| Mar 31, 2024 | 22.70 Mn |
| Mar 31, 2024 | 22.70 Mn |